CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Early weight loss with liraglutide 3.0 mg is a good predictor of clinically meaningful weight loss after 56 weeks
DOI 10.1055/s-0036-1580953
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Blueher, T Wehrhahn, K Hermansen, F Greenway, K Fujioka, M Donsmark, C Jensen, J Wilding
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
This subgroup analysis of SCALE Obesity and Prediabetes and SCALE Diabetes reports key outcomes in adults achieving ≥5% WL from baseline at Week (W) 16 on liraglutide 3.0 mg (early responders; ER), compared to those who did not (early non-responders; ENR). 2910 adults (2487 without T2D, 423 with T2D) were randomised to liraglutide 3.0 mg with diet & exercise (D&E); 365 with T2D and 2159 without T2D completed to 16W.…
Zitieren
Zitierempfehlung
M Blueher, T Wehrhahn, K Hermansen, F Greenway, K Fujioka, M Donsmark, C Jensen, J Wilding (2016) Early weight loss with liraglutide 3.0 mg is a good predictor of clinically meaningful weight loss after 56 weeks. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0036-1580953
Mit CareLit weiterarbeiten